For the Inventor, By the Inventor

Enter assignee name

Wilmington, DE, United States of America

Astrazeneca Pharmaceuticals LP

USPTO Granted Patents = 38

CIPO Patents = 4

EPO Patents = 18

Trademarks = 2

Forward Citations = 305

Loading Chart...

Loading Chart...

75 inventors (with patents filed for the assignee):

Soumitra S Ghosh (15 out of 58 patents)

Odile Esther Levy (10 out of 29 patents)

David Geoffrey Parkes (10 out of 21 patents)

4. Christopher Joseph Soares (9 out of 23 patents)

5. Lawrence J D'Souza (9 out of 14 patents)

6. Carolyn M Jodka (8 out of 14 patents)

7. Andrew A Young (7 out of 68 patents)

8. Christine Marie Mack (7 out of 17 patents)

9. Alain D Baron (6 out of 32 patents)

10. Michael R Hanley (6 out of 26 patents)

11. Richard A Pittner (6 out of 11 patents)

12. Kathryn Susan Prickett (6 out of 38 patents)

13. Mary Erickson (5 out of 21 patents)

14. Diana Y Lewis (5 out of 10 patents)

15. Abhinandini Sharma (4 out of 4 patents)

38 patents: Sort by Forward Citations

1. 10789558 - Non-linear systems and methods for destination selection (2020-09-29),

2. 9884092 - Methods for treating diabetes and reducing body weight (2018-02-06),

3. 9593154 - Engineered polypeptides having enhanced duration of action (2017-03-14),

4. 9453063 - Hybrid polypeptides with selectable properties (2016-09-27),

5. 9382304 - Engineered polypeptides having enhanced duration of action with reduced immunogenicity (2016-07-05),

6. 9249181 - C-terminal amidation of polypeptides (2016-02-02),

7. 9248240 - Formulation delivery device (2016-02-02),

8. 9217022 - GLP-1 receptor agonist compounds having stabilized regions (2015-12-22),

9. 9133260 - GIP analog and hybrid polypeptides with selectable properties (2015-09-15),

10. 9034819 - Method of lowering cholesterol and triglycerides by administering exendins (2015-05-19),

11. 8951962 - Modified exendins and exendin agonists (2015-02-10),

12. 8946149 - Use of exendin and analogs thereof to delay or prevent cardiac remodeling (2015-02-03),

13. 8927687 - Microcrystalline Y receptor agonists (2015-01-06),

14. 8906851 - Method for treating diabetes (2014-12-09),

15. 8906849 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same (2014-12-09),

AstraZeneca Pharmaceuticals LP is a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. With a mission to improve the health and well-being of people worldwide, AstraZeneca conducts research in areas such as oncology, cardiovascular, respiratory, and immunology. Through innovation and collaboration, AstraZeneca strives to address the unmet medical needs of patients and make a meaningful impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

38 Patents

#120 in Wilmington, DE

#154 in Delaware

#8,727 in US

#17,314 in the World

Wilmington, DE, United States of America

Astrazeneca Pharmaceuticals LP

Forward Citations = 305

75 inventors:

Soumitra S Ghosh (15 out of 58 patents)

Odile Esther Levy (10 out of 29 patents)

David Geoffrey Parkes (10 out of 21 patents)

4. Christopher Joseph Soares (9 out of 23 patents)

5. Lawrence J D'Souza (9 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…